Sudha Ravishankar
AstraZeneca (India)(IN)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Cancer therapeutics and mechanisms, Antibiotic Resistance in Bacteria, Bacterial Genetics and Biotechnology, RNA and protein synthesis mechanisms
Most-Cited Works
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity(2014)94 cited
- → Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents(2014)89 cited
- → The Phosphatidyl- myo -Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo(2014)50 cited
- → Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target(2015)49 cited
- → Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System(2014)47 cited
- → Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis(2010)36 cited
- → Study of the Interaction between Bacteriophage T4 asiA andEscherichia coliς70, Using the Yeast Two-Hybrid System: Neutralization of asiA Toxicity toE. coliCells by Coexpression of a Truncated ς70Fragment(1999)29 cited
- → Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway(2016)28 cited
- → Assessment of Mycobacterium tuberculosis Pantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors(2014)27 cited